What question did this study set out to answer?

The aim is to develop a mucin nanocarrier that enhances mucoadhesion and drug delivery for treating ocular uveitis.

February 19, 2026Open Access

Natural gum modified mucin nanocarrier with enhanced mucoadhesion and transcornea infiltration for controlled drug delivery in ocular uveitis therapy

WAWahida Binte Naz AurthyBangladesh University of Engineering and Technology NDNondita DattaBangladesh University of Engineering and Technology SWSiew Yee Wong

Key Points

The aim is to develop a mucin nanocarrier that enhances mucoadhesion and drug delivery for treating ocular uveitis.
Developed a natural gum modified mucin nanocarrier.
Tested mucoadhesion and transcornea infiltration capabilities.
Evaluated drug release profiles for controlled delivery.
Increased mucoadhesion compared to traditional treatments.
Enhanced transcornea infiltration improves drug availability.
Demonstrated more effective drug release over time.

Abstract

Ocular uveitis are a major health concern due to the limited efficacy of current antibiotic eye drops. Conventional treatments require frequent application as they have less bioavailability and show slow...

KI fragen

Bookmark

View Full Paper